CLOCK and insomnia: This study investigated duration-dependent alterations in cAMP-mediated signaling and clock gene expression that occur during and after exposure to ramelteon, a selective MT1/MT2 agonist used to treat insomnia (Rozerem; Takeda Pharmaceutical Company, Osaka, Japan).